N-(3-(3,4-dichlorobenzyl)-4-oxo-3,4-dihydroquinazolin-6-yl)-2-hydroxyacetamide

ID: ALA444433

PubChem CID: 25158453

Max Phase: Preclinical

Molecular Formula: C17H13Cl2N3O3

Molecular Weight: 378.21

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CO)Nc1ccc2ncn(Cc3ccc(Cl)c(Cl)c3)c(=O)c2c1

Standard InChI:  InChI=1S/C17H13Cl2N3O3/c18-13-3-1-10(5-14(13)19)7-22-9-20-15-4-2-11(21-16(24)8-23)6-12(15)17(22)25/h1-6,9,23H,7-8H2,(H,21,24)

Standard InChI Key:  ZZCPRLFJMWBCSV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -2.7167  -12.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7167  -13.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0046  -13.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0046  -11.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2926  -12.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2961  -13.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5874  -13.4424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1294  -13.0352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1329  -12.2102    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5804  -11.7924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5780  -10.9674    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8496  -11.8015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5619  -12.2177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5554  -13.0427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2668  -13.4589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9845  -13.0501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9862  -12.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2741  -11.8084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4323  -11.7938    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1456  -12.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8613  -11.7979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1432  -13.0333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5745  -12.2125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7013  -11.8096    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.6973  -13.4654    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  9 12  1  0
  1  2  1  0
 12 13  1  0
  1  4  2  0
 13 14  2  0
  2  3  2  0
 14 15  1  0
  3  6  1  0
 15 16  2  0
  5  4  1  0
 16 17  1  0
  5 10  1  0
 17 18  2  0
 18 13  1  0
  6  7  1  0
  1 19  1  0
  7  8  2  0
 19 20  1  0
  8  9  1  0
 20 21  1  0
  9 10  1  0
 20 22  2  0
  5  6  2  0
 21 23  1  0
 10 11  2  0
 17 24  1  0
 16 25  1  0
M  END

Associated Targets(Human)

Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCD Tchem Acyl-CoA desaturase (1011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Scd1 Acyl-CoA desaturase 1 (506 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fads1 Fatty acid desaturase 1 (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fads2 Fatty acid desaturase 2 (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.21Molecular Weight (Monoisotopic): 377.0334AlogP: 2.68#Rotatable Bonds: 4
Polar Surface Area: 84.22Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.68CX Basic pKa: 4.65CX LogP: 2.30CX LogD: 2.30
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.73Np Likeness Score: -1.73

References

1. Koltun DO, Vasilevich NI, Parkhill EQ, Glushkov AI, Zilbershtein TM, Mayboroda EI, Boze MA, Cole AG, Henderson I, Zautke NA, Brunn SA, Chu N, Hao J, Mollova N, Leung K, Chisholm JW, Zablocki J..  (2009)  Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors.,  19  (11): [PMID:19394219] [10.1016/j.bmcl.2009.04.004]
2. Koltun DO, Zilbershtein TM, Migulin VA, Vasilevich NI, Parkhill EQ, Glushkov AI, McGregor MJ, Brunn SA, Chu N, Hao J, Mollova N, Leung K, Chisholm JW, Zablocki J..  (2009)  Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors.,  19  (15): [PMID:19577469] [10.1016/j.bmcl.2009.06.017]
3. Deng Y, Yang Z, Shipps GW, Lo SM, West R, Hwa J, Zheng S, Farley C, Lachowicz J, van Heek M, Bass AS, Sinha DP, Mahon CR, Cartwright ME..  (2013)  Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1).,  23  (3): [PMID:23265904] [10.1016/j.bmcl.2012.11.075]

Source